If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
12th May 20152:18 pmRNSDirector/PDMR Shareholding
5th May 201510:08 amRNSHolding(s) in Company
30th Apr 20154:26 pmRNSAnnual Financial Report
28th Apr 20153:57 pmRNSDirector/PDMR Shareholding
21st Apr 20153:10 pmRNSDirector/PDMR Shareholding
20th Apr 20151:07 pmRNSDirector/PDMR Shareholding
10th Apr 20157:00 amRNSAudited Preliminary Results
10th Mar 20154:02 pmRNSHuntsworth plc - Notice of Preliminary Results
12th Feb 201511:03 amRNSChief Executive Update
2nd Feb 20152:07 pmRNSTotal Voting Rights
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
22nd Dec 20142:54 pmRNSDirector/PDMR Shareholding
22nd Dec 201411:21 amRNSAppointment of new Chief Executive
19th Dec 20144:21 pmRNSDirector Declaration
19th Dec 201411:25 amRNSDirectorate Change
15th Dec 20144:35 pmRNSPrice Monitoring Extension
9th Dec 201410:06 amRNSHolding(s) in Company
5th Dec 20144:40 pmRNSSecond Price Monitoring Extn
5th Dec 20144:35 pmRNSPrice Monitoring Extension
1st Dec 201412:03 pmRNSBlocklisting Interim Review
20th Nov 20144:21 pmRNSDirectorate Change
3rd Nov 20149:31 amRNSTotal Voting Rights
28th Oct 20149:30 amRNSAdditional Listing
8th Oct 201410:09 amRNSDividend Declaration
7th Oct 20143:15 pmRNSDirectorate Change
1st Sep 20149:32 amRNSTotal Voting Rights
11th Aug 20144:56 pmRNSDirector/PDMR Shareholding - Replacement
11th Aug 20142:05 pmRNSDirector Declaration
11th Aug 20141:08 pmRNSDirector/PDMR Shareholding
11th Aug 20147:00 amRNSInterim results for the six months to 30 June 2014
6th Aug 20148:51 amRNSNotice of Results
1st Aug 201410:18 amRNSTotal Voting Rights
31st Jul 20143:08 pmRNSHolding(s) in Company
14th Jul 201410:10 amRNSDirector Update
14th Jul 20147:00 amRNSHuntsworth Trading Update
7th Jul 20149:36 amRNSHolding(s) in Company
3rd Jul 201412:34 pmRNSAdditional Listing
26th Jun 20149:16 amRNSNotification of Board Changes
25th Jun 20143:32 pmRNSHolding(s) in Company
24th Jun 201411:33 amRNSResult of AGM
4th Jun 20142:38 pmRNSScript Dividend Alternative
3rd Jun 201412:13 pmRNSBlocklisting Interim Review
27th May 20149:37 amRNSNotice of AGM
16th May 20142:59 pmRNSInterim Management Statement
2nd May 20141:51 pmRNSDirector/PDMR Shareholding
30th Apr 20143:31 pmRNSAnnual Financial Report
29th Apr 20147:00 amRNSAudited Preliminary Results 2013
28th Apr 20147:00 amRNSNotification of Board Changes
25th Apr 201410:51 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.